These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Neurogenic orthostatic hypotension in Parkinson's disease: evaluation, management, and emerging role of droxidopa. Isaacson SH; Skettini J Vasc Health Risk Manag; 2014; 10():169-76. PubMed ID: 24729712 [TBL] [Abstract][Full Text] [Related]
5. L-threo-dihydroxyphenylserine (L-threo-DOPS; droxidopa) in the management of neurogenic orthostatic hypotension: a multi-national, multi-center, dose-ranging study in multiple system atrophy and pure autonomic failure. Mathias CJ; Senard JM; Braune S; Watson L; Aragishi A; Keeling JE; Taylor MD Clin Auton Res; 2001 Aug; 11(4):235-42. PubMed ID: 11710796 [TBL] [Abstract][Full Text] [Related]
6. Adjusting droxidopa for neurogenic orthostatic hypotension in a patient with Parkinson disease. Goodman BP; Claassen D; Mehdirad A Clin Auton Res; 2017 Jul; 27(Suppl 1):17-19. PubMed ID: 28631223 [No Abstract] [Full Text] [Related]
7. Titrating droxidopa to maximize symptomatic benefit in a patient with Parkinson disease and neurogenic orthostatic hypotension. Gupta F; Karabin B; Mehdirad A Clin Auton Res; 2017 Jul; 27(Suppl 1):15-16. PubMed ID: 28699047 [No Abstract] [Full Text] [Related]
8. Standing and Supine Blood Pressure Outcomes Associated With Droxidopa and Midodrine in Patients With Neurogenic Orthostatic Hypotension: A Bayesian Meta-analysis and Mixed Treatment Comparison of Randomized Trials. Chen JJ; Han Y; Tang J; Portillo I; Hauser RA; Dashtipour K Ann Pharmacother; 2018 Dec; 52(12):1182-1194. PubMed ID: 29972032 [TBL] [Abstract][Full Text] [Related]
9. Safety and Durability of Effect with Long-Term, Open-Label Droxidopa Treatment in Patients with Symptomatic Neurogenic Orthostatic Hypotension (NOH303). Isaacson S; Shill HA; Vernino S; Ziemann A; Rowse GJ J Parkinsons Dis; 2016 Oct; 6(4):751-759. PubMed ID: 27636856 [TBL] [Abstract][Full Text] [Related]
10. Droxidopa for the short-term treatment of symptomatic neurogenic orthostatic hypotension in Parkinson's disease (nOH306B). Hauser RA; Isaacson S; Lisk JP; Hewitt LA; Rowse G Mov Disord; 2015 Apr; 30(5):646-54. PubMed ID: 25487613 [TBL] [Abstract][Full Text] [Related]
11. Substantial renal conversion of L-threo-3,4-dihydroxyphenylserine (droxidopa) to norepinephrine in patients with neurogenic orthostatic hypotension. Lamotte G; Holmes C; Sullivan P; Goldstein DS Clin Auton Res; 2019 Feb; 29(1):113-117. PubMed ID: 30229336 [TBL] [Abstract][Full Text] [Related]
12. Cost-effectiveness of droxidopa in patients with neurogenic orthostatic hypotension: post-hoc economic analysis of Phase 3 clinical trial data. François C; Hauser RA; Aballéa S; Dorey J; Kharitonova E; Hewitt LA J Med Econ; 2016; 19(5):515-25. PubMed ID: 26710315 [TBL] [Abstract][Full Text] [Related]
13. Randomized withdrawal study of patients with symptomatic neurogenic orthostatic hypotension responsive to droxidopa. Biaggioni I; Freeman R; Mathias CJ; Low P; Hewitt LA; Kaufmann H; Hypertension; 2015 Jan; 65(1):101-7. PubMed ID: 25350981 [TBL] [Abstract][Full Text] [Related]
14. Integrated analysis of droxidopa trials for neurogenic orthostatic hypotension. Biaggioni I; Arthur Hewitt L; Rowse GJ; Kaufmann H BMC Neurol; 2017 May; 17(1):90. PubMed ID: 28494751 [TBL] [Abstract][Full Text] [Related]
15. Droxidopa in patients with neurogenic orthostatic hypotension associated with Parkinson's disease (NOH306A). Hauser RA; Hewitt LA; Isaacson S J Parkinsons Dis; 2014; 4(1):57-65. PubMed ID: 24326693 [TBL] [Abstract][Full Text] [Related]
16. Diagnosing and treating neurogenic orthostatic hypotension in primary care. Kuritzky L; Espay AJ; Gelblum J; Payne R; Dietrich E Postgrad Med; 2015; 127(7):702-15. PubMed ID: 26012731 [TBL] [Abstract][Full Text] [Related]
17. The treatment of neurogenic orthostatic hypotension with 3,4-DL-threo-dihydroxyphenylserine: a randomized, placebo-controlled, crossover trial. Freeman R; Landsberg L; Young J Neurology; 1999 Dec; 53(9):2151-7. PubMed ID: 10599797 [TBL] [Abstract][Full Text] [Related]
18. Persistent unexplained chest pain and dyspnea in a patient with coronary artery disease: a case report. Mobarek SK BMC Cardiovasc Disord; 2020 Feb; 20(1):54. PubMed ID: 32019498 [TBL] [Abstract][Full Text] [Related]